Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT00576758
Status:
COMPLETED
Last Update Posted:
2014-08-19
First Post:
2007-12-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-01
Start Date Type:
None
Primary Completion Date:
2011-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-18
First Submit QC Date:
None
Study First Post Date:
2007-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-11-27
Results First Submit QC Date:
None
Results First Post Date:
2014-03-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-15
Last Update Post Date:
2014-08-19
Last Update Post Date Type:
ESTIMATED